524 related articles for article (PubMed ID: 22042971)
1. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
Koelz M; Lense J; Wrba F; Scheffler M; Dienes HP; Odenthal M
Int J Oncol; 2011 Feb; 38(2):503-11. PubMed ID: 21132270
[TBL] [Abstract][Full Text] [Related]
3. Survivin is a novel transcription regulator of KIT and is downregulated by miRNA-494 in gastrointestinal stromal tumors.
Yun S; Kim WK; Kwon Y; Jang M; Bauer S; Kim H
Int J Cancer; 2018 May; 142(10):2080-2093. PubMed ID: 29277888
[TBL] [Abstract][Full Text] [Related]
4. miR-148b-3p functions as a tumor suppressor in GISTs by directly targeting KIT.
Wang Y; Li J; Kuang D; Wang X; Zhu Y; Xu S; Chen Y; Cheng H; Zhao Q; Duan Y; Wang G
Cell Commun Signal; 2018 Apr; 16(1):16. PubMed ID: 29661252
[TBL] [Abstract][Full Text] [Related]
5. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
[TBL] [Abstract][Full Text] [Related]
6. The rs17084733 variant in the
Ravegnini G; Serrano C; Simeon V; Sammarini G; Nannini M; Roversi E; Urbini M; Ferrè F; Ricci R; Tarantino G; Pantaleo MA; Hrelia P; Angelini S
Epigenetics; 2019 Jun; 14(6):545-557. PubMed ID: 30983504
[TBL] [Abstract][Full Text] [Related]
7. Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions.
Haller F; Löbke C; Ruschhaupt M; Schulten HJ; Schwager S; Gunawan B; Armbrust T; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
J Pathol; 2008 Oct; 216(2):225-35. PubMed ID: 18729075
[TBL] [Abstract][Full Text] [Related]
8. Effects of imatinib vary with the types of KIT-mutation in gastrointestinal stromal tumor cell lines.
Noma K; Naomoto Y; Gunduz M; Matsuoka J; Yamatsuji T; Shirakawa Y; Nobuhisa T; Okawa T; Takaoka M; Tomono Y; Hiroyuki O; Gunduz E; Tanaka N
Oncol Rep; 2005 Sep; 14(3):645-50. PubMed ID: 16077968
[TBL] [Abstract][Full Text] [Related]
9. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
[TBL] [Abstract][Full Text] [Related]
10. Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31.
Haller F; von Heydebreck A; Zhang JD; Gunawan B; Langer C; Ramadori G; Wiemann S; Sahin O
J Pathol; 2010 Jan; 220(1):71-86. PubMed ID: 19768731
[TBL] [Abstract][Full Text] [Related]
11. [Expression and gene mutation of phospho-platelet derived growth factor receptor alpha and C-kit in gastrointestinal and extra-gastrointestinal stromal tumors].
Tang M; Li DQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):80-3. PubMed ID: 18197502
[TBL] [Abstract][Full Text] [Related]
12. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site.
Antonescu CR; Viale A; Sarran L; Tschernyavsky SJ; Gonen M; Segal NH; Maki RG; Socci ND; DeMatteo RP; Besmer P
Clin Cancer Res; 2004 May; 10(10):3282-90. PubMed ID: 15161681
[TBL] [Abstract][Full Text] [Related]
13. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
[TBL] [Abstract][Full Text] [Related]
14. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of ETV1 and its contribution to tumorigenic phenotypes in gastrointestinal stromal tumors.
Zhang Y; Gu ML; Zhou XX; Ma H; Yao HP; Ji F
Oncol Rep; 2014 Sep; 32(3):927-34. PubMed ID: 24970355
[TBL] [Abstract][Full Text] [Related]
16. Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred.
Li FP; Fletcher JA; Heinrich MC; Garber JE; Sallan SE; Curiel-Lewandrowski C; Duensing A; van de Rijn M; Schnipper LE; Demetri GD
J Clin Oncol; 2005 Apr; 23(12):2735-43. PubMed ID: 15837988
[TBL] [Abstract][Full Text] [Related]
17. MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor.
Liu S; Cui J; Liao G; Zhang Y; Ye K; Lu T; Qi J; Wan G
Tumour Biol; 2014 Sep; 35(9):9131-8. PubMed ID: 25027394
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
[TBL] [Abstract][Full Text] [Related]
19. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
20. miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours.
Ihle MA; Trautmann M; Kuenstlinger H; Huss S; Heydt C; Fassunke J; Wardelmann E; Bauer S; Schildhaus HU; Buettner R; Merkelbach-Bruse S
Mol Oncol; 2015 Aug; 9(7):1421-33. PubMed ID: 25898773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]